Treatment Effectiveness
User reported effectiveness ratings Neurontin for various conditions.
Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
---|---|---|---|---|---|---|
Lower Back Pain | 9% | 22% | 7% | 51% | 11% | 55 |
Migraine | 7% | 13% | 9% | 64% | 7% | 209 |
Restless Legs Syndrome | 7% | 47% | 10% | 33% | 3% | 30 |
Insomnia | 13% | 25% | 0% | 50% | 13% | 8 |
Side Effects
User-reported side effects of Neurontin
Side Effect | Percent of Reports Neurontin |
---|---|
Diarrhea | 15% |
Constipation | 27% |
Dry Mouth | 37% |
Heartburn | 17% |
Back or Joint Pain | 26% |
Diarhea | 12% |
Difficulty Concentrating or Paying Attention | 54% |
Dizziness | 47% |
Double or Blurred Vision | 24% |
Drowsiness | 61% |
Ear Pain | 11% |
Fever | 5% |
Memory Problems | 49% |
Mental Slowness | 46% |
Red, Itchy Eyes (Sometimes With Swelling or Discharge) | 11% |
Runny Nose, Sneezing, Cough, Sore Throat, or Flu-Like Symptoms | 15% |
Shaking of a Part of Your Body That You Cannot Control | 15% |
Speech Problems | 22% |
Strange or Unusual Thoughts | 23% |
Swelling of the Hands, Feet, Ankles, or Lower Legs | 22% |
Tiredness or Weakness | 58% |
Unsteadiness | 39% |
Unwanted Eye Movements | 10% |
VAGINAL ODOR | 6% |
Vomiting | 5% |
Water Retension | 12% |
Water Retention | 12% |
Weight Gain | 34% |
"High" or Elevated Mood | 16% |
Anxiety | 31% |
Headache | 29% |
Nausea | 22% |
Outcomes
Below is the degree of change seen after Neurontin is higher than average.

Outcomes Label
Outcomes
of
Below is the change in the listed outcome after
is higher than average.
(Math.abs(a['change']) < Math.abs(b['change'])) ? 1 : -1)" title="Click to put the results with the largest observed change at the top">
Sort by Effect Size
(a['number_of_days'] < b['number_of_days']) ? 1 : -1)" title="Click to put the results with the most supporting data points at the top.">
Sort by Confidence
Neurontin Info
Property | Value |
---|---|
Variable Name | Neurontin |
Aggregation Method | SUM |
Analysis Performed At | 2020-04-02 |
Duration of Action | 21 days |
Filling Value | 0 |
Minimum Allowed Value | 0 count |
Number of Aggregate Predictors | 0 |
Number of Aggregate Outcomes | 0 |
Number of Measurements | 0 |
Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
Public | true |
Onset Delay | 30 minutes |
Unit | Count |
User Variables | 0 |
Variable Category | Treatments |
Variable ID | 94555 |